The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE air defences respond to fresh wave of missile threats, Sunday morning
UAE responds to more missile, drone threats on Saturday
Over 3.2 million visit Sheikh Zayed Grand Mosque Centre during Ramadan, Eid
UAE joins 21 nations in condemning Iranian attacks, closure of Strait of Hormuz
UAE sends condolences to South Korea over factory fire
DoE Chairman reviews efficiency of Abu Dhabi's energy, water ecosystem
UAE intercepts 3 ballistic missiles, 8 drones on Saturday
Mother's Day: UAE leaders pay special tribute to mothers of fallen heroes
Dubai extends truck movement exemption 'until further notice'
UAE warns of unstable weather conditions across the country
Abu Dhabi affirms readiness for adverse weather conditions in UAE
UAE President holds Eid calls with regional leaders
Jordan, Egypt strongly condemn terrorist plot targeting UAE
UAE cyber chief visits security centres during Eid
Abu Dhabi arrests 109 for filming and sharing inaccurate videos online
New bridges open linking Al Reem Island to Abu Dhabi highway
UAE President holds talks with Turkish Foreign Minister
